Capsant will be presenting at the In Vitro Toxicological Society meeting.
Bioversity
Dec 9th
London
Capsant will be presenting at the Bioversity Genesis conference this year.
Capsant tissue technologies
Capsant is developing a novel in-vitro tissue testing platform based around its revolutionary Hi-Spot technology.
Hi-Spots are 3 dimensional tissue engineered human or rodent ‘organ-like’ microdots formed onto a biochip for the purpose of multi-readout high throughput drug screening.
In comparison to other traditional in-vitro drug discovery technologies this platform has the potential to select safer and more effective drugs reducing the need for testing in animals.
Stem cells
Capsant is working with leading international stem cell groups to develop new ways to differentiate 3D tissues from human stem cells
Tissue Engineering
Capsant have pioneered the use of air liquid interface technology in the formation of reaggregated primary tissues
Capsant is working with leading international stem cell groups to develop new ways to differentiate 3D tissues from human stem cells
Capsant have pioneered the use of air liquid interface technology in the formation of reaggregated primary tissues
